PCSK9-IN-31
PCSK9-IN-31 (Compound WX002) is an orally active PCSK9 inhibitor. PCSK9-IN-31 can lower low-density lipoprotein cholesterol (LDL-C) and total cholesterol (TC) in high cholesterol fed model rats[1].
Product Specifications
CAS Number
2247649-76-7
UNSPSC
12352005
Target
PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/pcsk9-in-31.html
Smiles
CC1=C(N([C@H]2CNCCC2)C(C3=CC=C(C4=NOC(C)(C)C4=O)C=C3)=O)N=CC=C1
Molecular Formula
C23H26N4O3
Molecular Weight
406.48
References & Citations
[1]Wenjie Xu, et al. CRYSTAL FORM α OF COMPOUND A, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING CRYSTAL FORM. Patent. WO2020078170A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401045-500 1x 500 µL
CD16 (C16/1045), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740977-100 1x 100 µL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942988-500 1x 500 µL
BCL10 (MALT-Lymphoma Marker) (BL10/2988R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details